---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-009046"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2022-05-10T23:59:59+00:00"
generated_at: "2026-06-25T21:26:56.643030+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# OraSure Q1 record revenue $67.7M (+16% YoY) but net loss $20M, InteliSwab scales

## Summary
- Net loss of $20.0M ($0.28 diluted EPS) vs net income of $3.8M ($0.05) in Q1 2021; operating loss $16.0M.
- Record revenue $67.7M (+16% YoY); non-COVID revenue up 21%; InteliSwab revenue $22.1M (50% sequential growth).
- Gross margin fell to 36% from 65% due to InteliSwab scrap, under-absorption, product mix, and subsidy expiration.
- Cash from ops used $35.8M; cash and investments $112.2M; $16.9M committed for DoD capacity expansion to be reimbursed.
- Strategic alternatives review ongoing; CEO search underway with interim CEO Nancy Gagliano not a candidate.

## SEC filing metadata
- accession: 0000950170-22-009046
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2022-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000095017022009046/0000950170-22-009046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000095017022009046/osur-20220510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-009046
- JSON: https://secwatch.observer/filing/0000950170-22-009046.json
- Plain text: https://secwatch.observer/filing/0000950170-22-009046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.